Goldberg Jeff Marc 4
4 · Aeglea BioTherapeutics, Inc. · Filed Dec 1, 2022
Insider Transaction Report
Form 4
Goldberg Jeff Marc
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-29+1,884,838→ 1,884,838 totalExercise: $1.22Exp: 2032-11-28→ Common Stock (1,884,838 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/4 of the total award on November 29, 2023, and an additional 1/48 of the award will vest monthly thereafter until the option is 100% vested on November 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.